<DOC>
	<DOCNO>NCT00448903</DOCNO>
	<brief_summary>Chronic foot ulcer common , severe expensive complication patient diabetes often cause lower-extremity amputation . The aim study evaluate effect bemiparin treatment diabetic foot ulcer .</brief_summary>
	<brief_title>Clinical Trial Evaluate Efficacy Safety Sodium Bemiparin Treatment Diabetic Foot Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<criteria>Patients 18 year old give informed consent participate study . Patients type I II Diabetes Mellitus ( ADA Criteria ) . Presence chronic neuropathic inframalleolar diabetic foot ulcer ( start least 2 month ) , grade I II Wagner Classification , without significant improvement ( reduction ulcer area &gt; = 25 % ) within past 15 day prior inclusion . Ulcer size equal big 0.64 cm2 use follow formula : [ Major axis ] x [ Minor axis ] Anklebrachial index ( ABI ) &gt; = 0,7 Patients clinical symptom limbthreatening lifethreatening infection Presence bone exposure bottom ulcer and/or bone palpation catheter and/or presence radiological sign pathological fracture and/or bone sequesters Anklebrachial index ( ABI ) &lt; 0,7 Subjects arterial calcification ( ABI &gt; 1,3 ) negative tibial foot pulse cause Toe/Arm index ( T/A ) measure plethysmography ( photoplethysmography straingauge ) Subjects arterial calcification ( ABI &gt; 1,3 ) negative tibial foot pulse T/A index &lt; 0,55 measure plethysmography ( photoplethysmography straingauge ) Patients hematological disorder , organic lesion susceptible bleeding ( e.g . active peptic ulcer , stroke , aneurysm ) , severe arterial hypertension ( systolic blood pressure 200 mmHg and/or diastolic blood pressure 120 mmHg ) . Patients severe renal failure ( creatinine clearance &lt; 30 ml/min ) hepatic insufficiency ( AST and/or ALT value &gt; 5 time normal value establish reference range local hospital laboratory ) . Patients connective tissue disease Acute bacterial endocarditis slow endocarditis . Patients antithrombin deficit C S protein deficit . Patients HbA1C &gt; 12 % . Women pregnant breastfeeding , possibility become pregnant study . Known hypersensitivity LMWH , heparin substance porcine origin . Patients history heparininduced thrombocytopenia . Patients treatment anticoagulant therapy inclusion time past 15 day . Patients treatment pentoxifiline inclusion time past 30 day . Patients treatment systemic corticosteroid immunosuppressive therapy inclusion time past 3 month . Patients treatment beclapermin inclusion time past 15 day . Patients suffer revascularization endovascular surgery two month prior inclusion Patients life expectancy le 6 month . Patients complete schedule followup visit able complete study period . Patients participate another clinical trial do past 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>diabetic</keyword>
	<keyword>foot</keyword>
	<keyword>ulcer</keyword>
	<keyword>bemiparin</keyword>
	<keyword>neuropathy</keyword>
	<keyword>neuroishemic</keyword>
	<keyword>diabetes</keyword>
</DOC>